Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Dabigatran: From Thrombin Mechanism to Translation
2026-09-10
Dabigatran is more than a direct thrombin inhibitor: it is a translational tool for connecting molecular coagulation biology with clinically relevant assay design. This article examines how reversible inhibition of free and fibrin-bound thrombin can guide experimental strategy, how to build robust thrombin inhibition assays and coagulation function tests, and where clinical realities such as renal impairment, bleeding risk, metabolite activity, and formulation constrain interpretation. It also explains how the APExBIO research offering can support reproducible anticoagulation studies beyond the scope of a conventional product page.
-
SHC-1 Inhibition and CFTR Surface Trafficking
2026-09-10
Barros and colleagues show that MAPK/SHC-1-dependent CFTR internalization is detectable in airway and intestinal epithelial models, but pharmacological increases in surface CFTR are restricted to CFBE cells and are not fully selective. The study highlights both a conserved trafficking mechanism and an important limitation of relying on a single epithelial cell model to evaluate CFTR surface regulation.
-
Protease Inhibitor Cocktail for Plant Assays
2026-09-09
Protect plant root proteins during extraction, immunoblotting, co-immunoprecipitation, and kinase workflows with an EDTA-free, broad-spectrum inhibitor blend. The workflow is especially useful for studying nutrient-responsive NSP2–MYB40 signaling, where preserving native and phosphorylated proteins can determine whether a biologically meaningful interaction is detected.
-
Estradiol A8425 for Reproducible Cell Assays
2026-09-09
This scenario-based guide explains how Estradiol (SKU A8425) can improve experimental control in estrogen-receptor, viability, proliferation, and cytotoxicity workflows. It covers formulation choice, solvent controls, protocol parameters, interpretation limits, and practical supplier-selection criteria.
-
JSH-23: Mechanistic NF-κB Inhibition in Macrophages
2026-09-08
JSH-23 is an NF-κB inhibitor that separates p65 nuclear activity from upstream IκB degradation. This article develops a mechanistic assay strategy linking macrophage inflammation research with inflammasome biology and disease-model interpretation.
-
Epoxomicin and the Proteasome Logic of Viral Inflammation
2026-09-08
Epoxomicin offers a precise way to test whether proteasome-dependent protein turnover links viral immune evasion to RIPK3-driven inflammation. This thought-leadership guide translates the vIRD findings from Immunity into experimental strategy, assay controls, translational boundaries, and a practical framework for using Epoxomicin as a mechanistic proteasome inhibitor.
-
Amiloride (MK-870) in Ion-Transport Assay Design
2026-09-07
Amiloride (MK-870) is a versatile probe for sodium channel research, PC2-associated ion transport, and uPAR-linked cellular processes. This guide develops a cross-domain assay strategy connecting ion-flux controls with emerging ER-targeted nanovaccine research while clearly defining experimental boundaries.
-
Quercetin, Hippo Signaling, and Cataract Protection
2026-09-07
A 2025 study links quercetin-mediated protection of cataractous lenses to suppression of Hippo pathway activity, reduced oxidative stress, and improved lens epithelial-cell survival. Its combined network-pharmacology, mouse, and cell-culture design provides a useful framework for testing pathway-dependent protection while highlighting important limits in translating these findings to other signaling systems.
-
O6-Benzylguanine: MGMT Inhibition Workflows
2026-09-05
Use O6-Benzylguanine to separate direct MGMT blockade from transcriptional resistance mechanisms and to design stronger alkylator-sensitization experiments. This practical guide covers stock preparation, combination assays, DNA-damage readouts, controls, and troubleshooting for cancer chemotherapy research.
-
Berberine Hydrochloride: Mechanisms & Bench Use
2026-09-04
Berberine hydrochloride is an isoquinoline alkaloid salt used in metabolic disease research, diabetes and obesity models, lipid metabolism modulation, and cancer assays. Its most relevant experimental signals include AMPK activation, LDL receptor upregulation, and model-dependent regulation of apoptosis and ferroptosis pathways.
-
Cas9 mRNA–gRNA Delivery for LGMN Editing
2026-09-04
The reference study shows that lipid nanoparticle co-delivery of Cas9 mRNA and guide RNA can edit LGMN and reduce breast cancer cell migration, invasion, and metastatic behavior. Its main methodological contribution is an integrated workflow that compares guide-RNA template formats, optimizes Cas9 mRNA production, and links editing efficiency with lysosomal, autophagic, and tumor-cell phenotypes.
-
Firefly Luciferase mRNA: A Practical Assay Workflow
2026-09-03
Build more reliable transfection controls, gene expression assays, and LNP comparisons with a modified firefly reporter designed for efficient translation. This guide connects bench-ready handling and troubleshooting with practical lessons from recent mRNA-LNP research, while distinguishing reporter performance from immune or therapeutic efficacy.
-
HyperScribe T7 High Yield RNA Synthesis Kit Workflow
2026-09-03
Build a dependable T7 RNA polymerase transcription workflow for high-yield, capped, biotinylated, or dye-labeled research RNA. This guide connects reaction design and troubleshooting with practical mRNA, RNA interference, hybridization, and preclinical nanoparticle-assay use cases.
-
MLN2238: Proteasome β5 Subunit Inhibitor Workflows
2026-09-02
MLN2238 enables controlled chymotrypsin-like proteasome inhibition for apoptosis, proteostasis, multiple myeloma, lymphoma, and drug-resistance studies. This guide combines formulation strategy, dose-response design, ROS/JNK/CREB pathway assays, and troubleshooting for more reproducible experiments.
-
HyperFluor™ 488 Goat Anti-Mouse IgG Guide
2026-09-02
Learn how HyperFluor™ 488 Goat Anti-Mouse IgG (H+L) Antibody, SKU K1204, can improve mouse-IgG detection in immunofluorescence, flow cytometry, and western blot workflows supporting cell viability, proliferation, and cytotoxicity studies. The guide connects practical assay controls, storage, optimization, and interpretation with evidence from an endothelial radiation-injury model.